What's Happening?
The Royal Pharmaceutical Society (RPS) Assembly convened to discuss the future of its Faculty program, which has been recommended for closure. The program, launched in 2013, allowed members to gain recognition for advanced professional levels. Due to declining participation and the rise of credentialing, the RPS plans to focus on credentialing as a means of professional development. The Assembly also addressed recruitment for the Science and Research Committee and motions from the Annual General Meeting, including public policy on AI and copyright.
AD
Why It's Important?
The decision to close the Faculty program marks a significant shift in the RPS's approach to professional development. Credentialing is seen as a more effective way to ensure continued professional practice, particularly for patient-facing roles. This change reflects broader trends in professional recognition and development within the pharmaceutical industry. The discussions on AI and copyright policy highlight the RPS's commitment to addressing emerging challenges in the field, ensuring that pharmacists are equipped to navigate evolving technological landscapes.
What's Next?
The RPS will implement a roadmap for the closure of the Faculty program, allowing current participants to complete their recognition process by March 2026. The Society will explore credentialing for non-patient facing roles and continue to develop policies on AI and copyright. The Assembly plans to hold member events and surveys to gather feedback on these initiatives. The next Assembly meeting is scheduled for November 2025, where further updates and progress will be discussed.
